Evolus (EOLS) Total Liabilities (2017 - 2026)
Evolus' (EOLS) quarterly Total Liabilities came in at $249.4 million in Q1 2026, up 13.39% YoY from $220.0 million in Q1 2025, and little changed on a QoQ basis from $249.0 million in Q4 2025.
Evolus (EOLS) Total Liabilities (2017 - 2026) Analysis & Trends
Evolus (EOLS) has 10 years of Total Liabilities data on file, last reported at $249.4 million in Q1 2026.
- Quarterly Total Liabilities rose 13.39% year-over-year to $249.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $249.4 million (up 13.39% YoY) and the FY2025 annual result came in at $249.0 million, up 9.66% from the prior year.
- Total Liabilities steadied at $249.4 million in Q1 2026, from $249.0 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $249.4 million in Q1 2026 to a low of $153.3 million in Q1 2023.
- A 5-year average of $203.1 million and a median of $209.7 million in 2023 frame the typical range for Total Liabilities.
- The widest YoY moves for Total Liabilities: up 38.77% in 2022, down 9.18% in 2022.
- Tracing EOLS's Total Liabilities over 5 years: stood at $159.5 million in 2022, then soared by 31.48% to $209.7 million in 2023, then grew by 8.28% to $227.0 million in 2024, then gained by 9.66% to $249.0 million in 2025, then climbed by 0.18% to $249.4 million in 2026.
- The last three Total Liabilities figures came in at $249.4 million (Q1 2026), $249.0 million (Q4 2025), and $247.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.31 Bn | 43.35 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.75 Bn | 40.09 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 32.76 Bn | 31.08 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.31 Bn | 19.65 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.89 Bn | 18.00 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 12.00 Bn | 11.47 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 2.12 Bn |
| 10 | Evolus | 547.21 Mn | 502.04 Mn | 57.18 Mn | 278.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 278.93 Mn |
| Mar 31, 2026 | 249.43 Mn |
| Dec 31, 2025 | 248.97 Mn |
| Sep 30, 2025 | 247.76 Mn |
| Jun 30, 2025 | 247.46 Mn |
| Mar 31, 2025 | 219.97 Mn |
| Dec 31, 2024 | 227.05 Mn |
| Sep 30, 2024 | 223.72 Mn |
| Jun 30, 2024 | 214.46 Mn |
| Mar 31, 2024 | 207.73 Mn |
| Dec 31, 2023 | 209.69 Mn |
| Sep 30, 2023 | 187.34 Mn |
| Jun 30, 2023 | 175.95 Mn |
| Mar 31, 2023 | 153.29 Mn |
| Dec 31, 2022 | 159.48 Mn |
| Sep 30, 2022 | 163.50 Mn |
| Jun 30, 2022 | 164.06 Mn |
| Mar 31, 2022 | 153.41 Mn |
| Dec 31, 2021 | 175.61 Mn |
| Sep 30, 2021 | 117.82 Mn |